Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,265,880 | 894,240 | 887,430 | 772,560 | 693,040 |
| Marketable Securities | 575,190 | 591,540 | 470,120 | 344,840 | 312,220 |
| Receivables | 1,682,940 | 1,535,640 | 1,395,640 | 1,481,290 | 1,464,100 |
| Inventories | 1,940,400 | 1,869,300 | 1,659,680 | 1,642,060 | 1,618,320 |
| Other current assets | 42,000 | 83,820 | 58,690 | 62,350 | 60,470 |
| TOTAL | $5,506,410 | $4,974,540 | $4,471,560 | $4,303,100 | $4,148,150 |
| Non-Current Assets | |||||
| Investments And Advances | 50,190 | 81,800 | 92,000 | 378,140 | 381,000 |
| Other Non-Current Assets | 633,570 | 672,130 | 611,600 | 510,780 | 525,790 |
| TOTAL | $683,760 | $753,930 | $703,600 | $888,920 | $906,790 |
| Total Assets | $10,180,380 | $9,554,330 | $8,782,500 | $8,958,250 | $8,742,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 338,310 | 315,570 | 358,240 | 279,350 | 289,050 |
| Accrued Expenses | 175,350 | 233,760 | 170,930 | 237,910 | 232,580 |
| Other current liabilities | 1,704,360 | 1,657,040 | 1,354,240 | 1,446,330 | 1,369,620 |
| TOTAL | $2,315,250 | $2,330,790 | $1,957,940 | $1,991,710 | $1,908,820 |
| Non-Current Liabilities | |||||
| Long Term Debt | 195,300 | 186,720 | 176,820 | 209,420 | 210,320 |
| aiOther Non-Current Liabilities | 265,020 | 272,350 | 294,580 | 243,460 | 234,030 |
| TOTAL | $925,470 | $942,070 | $903,060 | $831,760 | $774,490 |
| Total Liabilities | $3,240,720 | $3,272,880 | $2,861,010 | $2,823,470 | $2,683,320 |
| Shareholders' Equity | |||||
| Common Shares | 133,140 | 130,040 | 119,040 | 119,690 | 117,100 |
| Retained earnings | 6,541,920 | 5,930,500 | 5,641,620 | 5,871,530 | 5,811,720 |
| Other shareholders' equity | 268,600 | 225,910 | 165,820 | 147,560 | 132,150 |
| TOTAL | $6,939,660 | $6,281,450 | $5,921,480 | $6,134,780 | $6,058,970 |
| Total Liabilities And Equity | $10,180,380 | $9,554,330 | $8,782,490 | $8,958,250 | $8,742,290 |